Preliminary Agenda

Day 1 | 9 September

‍

Opening Keynote: Kingsley Wheaton, BAT

‍

Module: The Brave New World: Global Supply & Trade in 2026 and Beyond An expansive look at the current state of global supply chains, international trade and related issues combined with prospective analysis of future trends. Panelists and keynotes will discuss issues related to different sectors of the global supply and value chain. Discussions will also focus on the current state of international trade and business with analysis of emerging and current geopolitical issues and market dynamics.

‍

Global Supply Chain: Challenges & Opportunities for Suppliers to the Industry: Hear from the trade experts and executives throughout the global supply chain on current and future trends, challenges, and perspectives.

Moderator: Laura Leigh Oyler, Haypp Group

Confirmed Speakers:

• Przemyslaw Pitura, Chemnovatic
• Ross Kirsh, Dymapak
• Rahul Mathew, Leaf N Beyond

Surviving in a Global Trade System: An expansive international trade focused panel that will cover cross border concerns from multi-national companies on issues such as taxes, tariffs, movement of goods and services across borders and trade zones, and labor concerns.

Moderator: Chris Greer, Stryk Brands

Confirmed Speakers:

• Markus Lindblad, Haypp Group
• Tadas Lisauskas, Greenbutts
• Greentank, TBD

Keynote: Jennifer Motles, Philip Morris International

Module: Quiet Transformation: Climate & Environment: An expansive international trade focused panel that will cover cross border concerns from multi-national companies on issues such as taxes, tariffs, movement of goods and services across borders and trade zones, and labor concerns

‍

Module Opening Keynote: Ben Dessart, Universal Corporation

‍

Innovative Responses to Climate Change & Global Climate Policy: explore the latest trends in climate policy, industry-government partnerships, and the innovative and transformative programs launched by nicotine industry participants.

Confirmed Speakers: 

• Ben Dessart, Universal Corporation
• Aylen Van Isseldyk, THR, Ethics, and Sustainability

‍

InFocus Talk: Big Data:

• Marina Murphy, Haypp Group

Day 2 | 10 September

‍

Module | Illicit Trade: The Other Risk Needing Reduction: Illicit trade has traditionally been seen as a brand protection or state revenue issue. But the truth is far more complex: illicit trade in tobacco and nicotine products not only frustrates public health goals, fuels criminal and terroristic organizations, dilutes markets, disincentivizes compliance, but also distorts risk calculations. Cheap illicit goods flood markets leading to policy action and market conditions which create incentives to proliferate illicit trade and drives consumers back to combustion. This module examines illicit trade through the lens of risk reduction and seeks to spark new solutions that fit the current environment. 

Moderator: Lillian Ortega, WOW Solutions

Confirmed Speakers:

Abel Vecino, PMI

‍

Playing Defense – Brand Protection and its Impact on Harm Reduction and Consumers: Global professionals from the largest companies deal with brand integrity and protection issues on a daily basis. Copycats do more than violate IP rights: learn how the fight to protect brand integrity is intricately linked to public health goals, nicotine (mis)perception, and the fight for harm reduction.

Module Keynote: US Illicit Trade

• Lillian Ortega, WOW Solutions

Troubled Waters: A tale of two approaches across the Tasmin Straight - Australia/New Zealand: Everywhere you hear about the contrasting approaches from two close neighbors. But the ANZAC experience is more than a thought exercise. GTNF is proud to platform the heads of the two main retailers groups in Australia and New Zealand to hear about the real state of play, the contrasts, and the struggles ahead.

Moderator: Beth Oliva, Fox Rothschild

Confirmed Speakers:

• Theo Foukkare, Australian Association of Convenience Stores
• David Hooker, New Zealand Association of Convenience Stores

Module: THE Ultra Marathon – Innovation in Science, Tech, and Products: Every conference you attend talks about ‘innovation’ and frankly we often find it to be a cliché. At GTNF we’re doing something about that. Innovation is a marathon fueled not by health bars but by Moore’s law. It is a natural source of tension generated by the yawning gap between policy and natural tech evolution. GTNF takes you through a consequential look at innovation. Covering everything from product stewardship advances, product development, utilization of data, to AI; GTNF covers it all.  

‍

Module Opening Keynote: Eve Wang, Smoore Technology  

‍

Panel: Innovation 360 from Three Unique Perspectives: Established Industry, Up & Comers; and Supporting Industry: Three panels with three different perspectives on the impacts, challenges, and opportunities of innovation. Hear from different segments of the tobacco and nicotine industry on not only the latest in innovation – but the ‘what,’ ‘how,’ and ‘why’ of innovation. What are the key challenges and opportunities present in today’s market and what forces outside of product development, science & R&D are impacting what, where, and how industry undertakes innovation. How product science and stewardship advances will change products and consumer preferences. Why change is not only inevitable but necessary.

Panel: Established Industry

Moderator: Eve Wang, Smoore Technology

‍

 Keynote: Roberto Sussman, Universidad Mexico (virtual)

‍

Panel: Innovation 360 – Up & Comers

• Moderator: Anna Franzen, Emplicure
• Yu Kang, Hangsen International
• Martin Miller, IKE Tech
• Fredrik Laurell, Nicoccino
• Ryan Selby, Emerald Innovations
• Ronan Barry, AIR

Panel: Innovation 360 – Supporting Industry

• Moderator: Sarah Marking, Sanova
• Chris Allen, Broughton Life Sciences
• Dean Cirotta, EAS Consulting Group
• Tim Phillips, Tamarind Intelligence
• Sairah Salim-Sartoni, Salim-Sartoni Associates Ltd

Day 3 | 11 September

‍

Module: Risk & Harm Reduction Full Story: For 20 years, the nicotine industry has been undergoing a risk and harm reduction transformation as established players and innovative start-ups seek to transition the world’s 1 billion nicotine consumers away from the highest risk products. Driven by technology, ethics, and business realities, all stakeholders contribute to the debate about harm reduction. But what is it – at a social level, how good are societies in managing risk not just with tobacco? Where are we on the road to real harm reduction within nicotine, and how is harm reduction being implemented next around the world? 

‍

Clinician’s Summit: An in-depth exploration of risk and harm reduction from practicing clinicians that covers comparative and contrasting approaches amongst multiple issues from obesity, diet, illicit drugs, alcohol, and tobacco use.

Confirmed Speakers:

• Jasjit Ahluwalia, Brown University
• Riccardo Polosa, CoEHAR

Leader Keynote: Maria Gogova, Altria Client Services

‍

TPD: Science Behind Legislation to Reduce Harm: TPD3 is one of the biggest headlines in tobacco and nicotine policy. Behind the punditry and headlines and clickable content is the important work of impirical evidence supporting regulations. This panel will examine the state of science and evidence and its impact on TPD3. 

• Moderator: Sud Patwardhan, Global Health Consortium
• Confirmed Speakers:

  Peter Beckett, Six Three One

  Nathalie Darge, Tobacco Europe

  Konstantinos Farsalinos, University of Patras, SPH

Leader Keynote: Maria Gogova, Altria Client Services

‍

Panel: The Forgotten Smoker: This panel will put the “Forgotten Smoker” at the center of an equity question: as smoking rates fall, the remaining harm is increasingly concentrated among adults facing the toughest barriers to quitting—or to switching away from cigarettes. In many countries, smoking-related disease is becoming a concentrated problem—carried disproportionately by adults who are hardest to reach with traditional cessation models. The barriers are familiar: financial stress, limited healthcare access, confusing or low-trust information environments, rural/remote geographies, and other structural constraints. This session compares what happens in very different settings: markets where smoke-free alternatives are restricted or banned, and markets where products may be legal but still effectively out of reach because of cost, misinformation, or gaps in support. The goal is a practical discussion of what sustainable tobacco control looks like when the metric is near-term disease reduction—responsible access, affordability, accurate information, and programs designed to reach the adults who are currently being left behind.

Moderator: Joe Williams, Altria Client Services

• Brian Erkkila, PMI
• Dave Dobbins, Dobbins Consulting

Panel: New Approaches to Harm Reduction: THR is awash in variables - dispirited populations, geographies, and cultures combined with the fact that harm reduction is multi-faceted and encompasses everything from social and environmental impacts to individual and population health - and this diversity cannot be managed as a global one-size-fits-all solution. From unintended consequences to outright frustration of public health goals, failing to adapt, learn and change approaches to THR has real consequences. This panel explores new approaches around the globe that are making progress, providing learning opportunities of adoption elsewhere, or are efforts worthy of a global stage.

• Moderator: Mohammadi Sarkar, Altria Client Services
• Sairah Salim-Sartoni, Salim-Sartoni Associates Ltd
• Elaine Round, RAI Services Company
• Juan Facundo Teme, THR, Ethics, and Sustainability
  

Panel: The Ban Wagon Effect: Do Bans Work: Product category, flavor, birthdates – are bans effective or simply creating new problems.

Moderator:

• Jessica Zdinak, ARAC

Confirmed Speakers:

• Alastair Mackay, PMI
• Chad Jones, Snubie.com‍
• Jeff Stier, Adviser to Heartland Institute
• Eveline Van Keymeulen, Latham & Watkins

‍

Does legislating a ban get rid of a problem? Bans are being proposed around the world in innovative and traditional forms: phased illegalization based on date of birth, constriction of product attributes and sales channels, and, of course, outright prohibitions. Measures are gaining traction from one geography to another. But if we dive deeper, what is a ban, and what does it actually do? Bans are simple and easy to package to constituents: "Because of X, we are banning Y." Simple messaging often belies more complexity in an issue hiding below the surface. This panel explores that complexity from why bans come about, what's standardized and what's unique to them, and, most importantly, to their highly complex effects: incentivization of illicit markets to satisfy demand; economic impacts from resource diversion for enforcement to losses throughout the value chain; and frustration of overarching THR and wider public health goals tied to consumer demand shifts to illicit products, backsliding to less harm-reduced ones, and social costs of the "illicitization" of products.   

Closing Harm Reduction Reaction Panel 

‍